TTM
$49.79B
YoY change
-4.6%
5Y CAGR
+10.9%
Peak year (2024)
$48.98B
Cumulative gross profit
$834.08B
Gross Profit history chart for Merck & Co. (MRK) from 1985 to 2025
Latest: $46.73B
Gross Profit growth chart for Merck & Co. (MRK) from 1985 to 2025
Latest: -4.6%
Gross Profit history table for Merck & Co. (MRK) from 1985 to 2025
| 2025 | $46.73B | -4.6% | −$2.24B | ||
| 2024 | $48.98B | +11.3% | +$4.99B | ||
| 2023 | $43.99B | +5.1% | +$2.12B | ||
| 2022 | $41.87B | +19.4% | +$6.79B | ||
| 2021 | $35.08B | +25.7% | +$7.18B | ||
| 2020 | $27.90B | +2.9% | +$795.00M | ||
| 2019 | $27.11B | -5.8% | −$1.68B | ||
| 2018 | $28.79B | +5.8% | +$1.57B | ||
| 2017 | $27.21B | +5.6% | +$1.43B | ||
| 2016 | $25.78B | +4.9% | +$1.21B | ||
| 2015 | $24.56B | -3.6% | −$905.00M | ||
| 2014 | $25.47B | -5.9% | −$1.61B | ||
| 2013 | $27.08B | -12.1% | −$3.74B | ||
| 2012 | $30.82B | -1.1% | −$355.00M | ||
| 2011 | $31.18B | +13.0% | +$3.58B | ||
| 2010 | $27.59B | +49.9% | +$9.18B | ||
| 2009 | $18.41B | +0.8% | +$142.00M | ||
| 2008 | $18.27B | +1.2% | +$210.00M | ||
| 2007 | $18.06B | +8.5% | +$1.42B | ||
| 2006 | $16.63B | -1.3% | −$227.40M | ||
| 2005 | $16.86B | -6.4% | −$1.14B | ||
| 2004 | $18.01B | -0.2% | −$41.90M | ||
| 2003 | $18.05B | +2.9% | +$510.30M | ||
| 2002 | $17.54B | -0.2% | −$35.50M | ||
| 2001 | $17.57B | -8.5% | −$1.62B | ||
| 2000 | $19.20B | +17.6% | +$2.87B | ||
| 1999 | $16.32B | +19.0% | +$2.60B | ||
| 1998 | $13.72B | +8.2% | +$1.04B | ||
| 1997 | $12.68B | +12.8% | +$1.44B | ||
| 1996 | $11.24B | +13.6% | +$1.35B | ||
| 1995 | $9.89B | +2.1% | +$203.30M | ||
| 1994 | $9.69B | +15.5% | +$1.30B | ||
| 1993 | $8.39B | +6.3% | +$499.30M | ||
| 1992 | $7.89B | +13.8% | +$956.20M | ||
| 1991 | $6.93B | +12.8% | +$784.20M | ||
| 1990 | $6.15B | +17.7% | +$925.50M | ||
| 1989 | $5.22B | +13.1% | +$603.60M | ||
| 1988 | $4.62B | +20.7% | +$791.30M | ||
| 1987 | $3.83B | +28.2% | +$842.20M | ||
| 1986 | $2.98B | +21.5% | +$527.20M | ||
| 1985 | $2.46B | — | — |
- 2025$46.73B-4.6%
- 2024$48.98B+11.3%
- 2023$43.99B+5.1%
- 2022$41.87B+19.4%
- 2021$35.08B+25.7%
- 2020$27.90B+2.9%
- 2019$27.11B-5.8%
- 2018$28.79B+5.8%
- 2017$27.21B+5.6%
- 2016$25.78B+4.9%
- 2015$24.56B-3.6%
- 2014$25.47B-5.9%
- 2013$27.08B-12.1%
- 2012$30.82B-1.1%
- 2011$31.18B+13.0%
- 2010$27.59B+49.9%
- 2009$18.41B+0.8%
- 2008$18.27B+1.2%
- 2007$18.06B+8.5%
- 2006$16.63B-1.3%
- 2005$16.86B-6.4%
- 2004$18.01B-0.2%
- 2003$18.05B+2.9%
- 2002$17.54B-0.2%
- 2001$17.57B-8.5%
- 2000$19.20B+17.6%
- 1999$16.32B+19.0%
- 1998$13.72B+8.2%
- 1997$12.68B+12.8%
- 1996$11.24B+13.6%
- 1995$9.89B+2.1%
- 1994$9.69B+15.5%
- 1993$8.39B+6.3%
- 1992$7.89B+13.8%
- 1991$6.93B+12.8%
- 1990$6.15B+17.7%
- 1989$5.22B+13.1%
- 1988$4.62B+20.7%
- 1987$3.83B+28.2%
- 1986$2.98B+21.5%
- 1985$2.46B—
Gross Profit values are taken from Merck & Co.'s reported income statements (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
About Gross Profit at Merck & Co. (MRK)
According to Merck & Co.'s latest reported financial statements, the company's current gross profit (TTM) is $49.79B. Gross profit equals revenue minus the cost of goods sold (COGS) — what remains from sales after the direct cost of producing the product or service. It does not yet subtract operating expenses, interest, or taxes (see operating income and net income for those steps). Higher gross profit (and gross margin) generally signals pricing power and production efficiency.
Headline TTM above sums the four reported quarters through (reported ). Chart and table below cover the full reported history back to .
The 2025 reading of Merck & Co. (MRK) gross profit is $46.73B – edged down 4.6% year-over-year.
Merck & Co. gross profit compound annual growth for the 2020–2025 (5 years) window is +10.9%, with mixed annual results across the window.
Merck & Co. gross profit edged down from $48.98B in 2024 to $46.73B in 2025, a 4.6% drawdown.
2024 marks the peak gross profit at $48.98B, with the historical low of $2.46B recorded in 1985.
Merck & Co. Gross Profit by Year
Merck & Co. Gross Profit 2025: $46.73B
Merck & Co. gross profit in 2025 was $46.73B, edged down 4.6% below 2024.
Merck & Co. Gross Profit 2024: $48.98B
2024's gross profit for Merck & Co. came in at $48.98B, grew 11.3% from 2023. This figure represents the highest annual value in the available history.
Merck & Co. Gross Profit 2023: $43.99B
Merck & Co. posted gross profit of $43.99B in 2023, grew 5.1% from 2022.
Merck & Co. Gross Profit 2022: $41.87B
In 2022, Merck & Co. reported gross profit of $41.87B, grew 19.4% from 2021.
Merck & Co. Gross Profit 2021: $35.08B
Merck & Co. gross profit in 2021 was $35.08B.
See more financial history for Merck & Co. (MRK).
Sector peers by Gross Profit
Healthcare peers of Merck & Co. (MRK), ranked by their latest gross profit
| $82.92B | |
| $68.56B | |
| $54.62B | |
| $48.11B | |
| $42.96B | |
| $39.01B | |
| $26.01B | |
| $16.78B |
- $82.92B
- $68.56B
- $54.62B
- $48.11B
- $42.96B
- $39.01B
- $26.01B
Frequently asked questions
Merck & Co. (MRK) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation